A detailed history of Certified Advisory Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Certified Advisory Corp holds 6,403 shares of MRK stock, worth $650,672. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,403
Previous 6,146 4.18%
Holding current value
$650,672
Previous $760,000 4.34%
% of portfolio
0.08%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $28,565 - $33,145
257 Added 4.18%
6,403 $727,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $68,585 - $73,659
554 Added 9.91%
6,146 $760,000
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $97,273 - $113,345
-859 Reduced 13.32%
5,592 $737,000
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $1.55 Million - $1.69 Million
-15,477 Reduced 70.58%
6,451 $703,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $1.62 Million - $1.8 Million
15,779 Added 256.61%
21,928 $2.26 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $8,145 - $8,878
-75 Reduced 1.21%
6,149 $709,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $88,940 - $99,239
864 Added 16.12%
6,224 $662,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $22,034 - $28,251
252 Added 4.93%
5,360 $594,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $8,030 - $9,021
-95 Reduced 1.83%
5,108 $440,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $1,502 - $1,703
18 Added 0.35%
5,203 $474,000
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $1,470 - $1,648
20 Added 0.39%
5,185 $426,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $12,865 - $16,116
178 Added 3.57%
5,165 $396,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $12,759 - $14,031
178 Added 3.7%
4,987 $374,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $25,522 - $28,230
363 Added 8.16%
4,809 $374,000
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $55,088 - $64,888
800 Added 21.94%
4,446 $342,000
Q2 2020

Jul 27, 2020

BUY
$70.42 - $80.13 $1,126 - $1,282
16 Added 0.44%
3,646 $282,000
Q1 2020

Apr 27, 2020

SELL
$63.36 - $87.82 $14,636 - $20,286
-231 Reduced 5.98%
3,630 $279,000
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $6,128 - $6,915
79 Added 2.09%
3,861 $351,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $16,205 - $17,664
213 Added 5.97%
3,782 $319,000
Q2 2019

Aug 07, 2019

SELL
$69.84 - $81.59 $3,911 - $4,569
-56 Reduced 1.54%
3,569 $299,000
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $4,244 - $4,840
61 Added 1.71%
3,625 $302,000
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $9,133 - $10,599
-140 Reduced 3.78%
3,564 $272,000
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $576 - $678
10 Added 0.27%
3,704 $263,000
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $5,845 - $6,867
115 Added 3.21%
3,694 $224,000
Q1 2018

Apr 30, 2018

BUY
$50.96 - $59.23 $14,982 - $17,413
294 Added 8.95%
3,579 $194,000
Q4 2017

Feb 22, 2018

BUY
$51.62 - $61.64 $169,571 - $202,487
3,285
3,285 $184,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Certified Advisory Corp Portfolio

Follow Certified Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.